Literature DB >> 7506174

A comparison of nimesulide and placebo in the treatment of minor traumatic soft tissue lesions in children.

M Giovannini1, G V Zuccotti, I Scaricabarozzi, V Locatelli, E Riva.   

Abstract

A total of 40 children with minor traumatic injuries of soft tissues were randomly assigned to oral treatment with nimesulide (50mg twice daily) or placebo for 5 days in a double-blind investigation. Results demonstrated that therapy with nimesulide was associated with a significant resolution of symptoms (pain at rest and during movement) and signs (oedema, immobility and haematoma), which was statistically superior to that demonstrated for placebo. Furthermore, nimesulide was well tolerated by all patients and was not associated with gastrointestinal problems. These findings suggest that nimesulide is a suitable therapy for children with minor traumatic lesions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506174     DOI: 10.2165/00003495-199300461-00054

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

2.  Pharmacokinetics and therapeutic study with nimesulide suppositories in children with post-operative pain and inflammation.

Authors:  A F Schärli; K Brülhart; T Monti
Journal:  J Int Med Res       Date:  1990 Jul-Aug       Impact factor: 1.671

3.  Antipyretic effects of nimesulide in paediatric practice: a double-blind study.

Authors:  J Lecomte; T Monti; M G Pochobradsky
Journal:  Curr Med Res Opin       Date:  1991       Impact factor: 2.580

4.  Non-steroidal anti-inflammatories--XII. Mode of action of anti-inflammatory methane sulfonanilides.

Authors:  C Rufer; E Schillinger; I Böttcher; W Repenthin; C Herrmann
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

  4 in total
  1 in total

Review 1.  Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  R Davis; R N Brogden
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.